CDSCO clearance for Biapenem injection to treat complicated urinary tract infections

December 11, 2021 0 By Gopakumar


ndia’s drug regulator Central Drugs Standard Control Organisation has cleared biapenem injection 300mg to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections. Biapenem, developed by BDR Pharma, belongs to a critical parenteral carbapenem antibacterial agent. However, the dosage of the drug is much lesser as compared to the existing class of carbapenems and has shown good clinical and bacteriological efficacy. Biapenem gets widely distributed and penetrates well into various tissues, including lung tissue, and body fluids like sputum, pleural effusion, abdominal cavity fluid.